Google TrendANNA BONDAR (200+) — October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Precision therapeutics an" (30 stories)

Top Headline Story

$25 million gift establishes Smilow precision center
Lead StoryPenn Medicinegeneral
2d ago

$25 million gift establishes Smilow precision center

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNZmxFWXh4UUE1UEZ3ZmdwcC1kbGY2cGJTWmtIcjRmbGotamEwVHpJanR0cjZYTzBLQ0dmczBVV2Nzc3VjNG1oRGJBVm5RaFF1UkRObUVoSlZ3czBxV2VMVUlBbG9wcEhCTURaUG5iaExsanVFU1E3SGdEUDFVZjcwSWxQcS1KMW52MjRBOWVn?oc=5" target="_blank">$25 million gift establishes Smilow precision center</a>  <font color="#6f6f6f">Penn Medicine</font>

Real-time search volume
200+18m ago

anna bondar

October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market

100+18m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

500+28m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

10000+28m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Search Results for "Precision therapeutics an"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Naturegeneral

Context-dependent synthetic lethality — an emerging precision therapeutic approach

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5kSEVYMEUyclRrc3FYQy1tSG5FN0dEQnpBR3E5aF9GLWtQVDNvRmxpeVl0SHB0dGQxRVA0VnBVN0JxNXhFSmY2TzNpMXlYNVNLNlJSUmZYRlRTSHBHc2Vv?oc=5" target="_blank">Context-dependent synthetic lethality — an emerging precision therapeutic approach</a>  <font color="#6f6f6f">Nature</font>

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches
Frontiersgeneral

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNWFpPeV9nNEtXLVNILXJTWDRoTjhaMm5MdW1nZ29pYi1vUkR0WWFnWEU3SnduNk14TENDdXFSeVJwQmpsZ05RTkFiYUNYMFNkczdnMGNSQ1Z5WHFmQ2RfWnFGMnRsWWdJWnRSM2xsYTEtSWFuQTE0MWU3NFNyV184NHRfVkdhd0JTT1I5S0lCbU5jQQ?oc=5" target="_blank">Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches</a>  <font color="#6f6f6f">Frontiers</font>

Scoop: Biotech KymaThera targets $75M raise for next-gen therapies
Axiostech

Scoop: Biotech KymaThera targets $75M raise for next-gen therapies

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNS2JkbVJDNzBMYV9RZFR3cnQ1UWxGRE0tZkN5SzctMXZYRHBscUFSVXNfdTJGWXplUkN3YjhPZjczV1hGTEpDWFFlMmQ5bnRoTW1xVFl6cnJaVEhTSlJvWkFFRmpQODFQd0t4MTZRdlhwSlNfQWQtZzFkOFF5Z2FyYW45NHMtcE5TVDd0ODFNd1FXWUVoUnd0dXB4X1ljXzItV0gw?oc=5" target="_blank">Scoop: Biotech KymaThera targets $75M raise for next-gen therapies</a>  <font color="#6f6f6f">Axios</font>

Reprogramming viral entry for precision therapeutics
Open Access Governmentgeneral

Reprogramming viral entry for precision therapeutics

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOa0FiSXV1eDVZekdmNGVadlNaZW5rbUlQOW1HY3dXczJWYlVwM3I1aF9xZi00ZTBjaV9McHRvc09NU0ZIbnJ1MjFfZTVFTFBuU1FrQlUzazNFVFFDeXhWSUtBeWFTTU5OcHdmeWg3NU5RVUdHX09zRHFqdU9XU1JUeEs3cWd6eGF6aFFsaVNNWXFOVDFLX2ZqRXhkb0wwNDZkR0puYnAwVDI?oc=5" target="_blank">Reprogramming viral entry for precision therapeutics</a>  <font color="#6f6f6f">Open Access Government</font>

Spatial RNA Medicine: The Next Frontier in Precision Therapeutics
News-Medicalgeneral

Spatial RNA Medicine: The Next Frontier in Precision Therapeutics

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNZEFCVl8wSUFXUE85MG13YXc2N1hQX2VQSU04ZUN5SEp1aVAxQlpaRktpa3NDNVJCTXE4aGJESmQyWTVzd2x2RWxZMHpSc0lockhRNTlXZUFsdjFhRnFaRlNVWjN1SWlHS1lLM2QwNTJKZnl5TGRvSmJGMThUaGRDSjNCY0l3bkphNTMzU2x4NzdtSFBQSzA4VUlfSm9UWWhhUno5ZXU5TUd5RjB4dVFIdS1B?oc=5" target="_blank">Spatial RNA Medicine: The Next Frontier in Precision Therapeutics</a>  <font color="#6f6f6f">News-Medical</font>

Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis
BioSpaceworld

Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis

<a href="https://news.google.com/rss/articles/CBMixgJBVV95cUxQQXZHZTNKNkhFckotSHdfbnZPb0hZSUFLQmdldzkxSEItRzIzbWJRc3ZvQjVrZ1kyeFRqNWxzQTlOeHJNdnhXbzZ3YktTXzdjcHpTLXM1cjFyYmlfM0xPakd5NzQ5M29ONmhHc3MxblFXb19CU3BhS1FDcU1jNjY1SXVsaDhvUzAxS2tzZTVQUi1rci1YNlNxN2ZiMFlOWW56UG5WQmdrZHhieFpESnh2eDhJU3pqcXVlYnhEMmhJbDNGX3liTDJiWWV0T1RyRDJiazVUZ2V4RnhFWGNBT1MteWNub0ZidzBNRi15WmxrdWJWZ0lUT2VYbG9iOXRHZFUxYjE0T2Z3d2VEd1d4RmdTMkp6Yjd3RnpBT3lpMWk5b2tNVFNDWmlMTXpMc0tkd19NMUExNFRDd2MwNGYySzVFeUxIMVg3QQ?oc=5" target="_blank">Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis</a>  <font color="#6f6f6f">BioSpace</font>

Genomic landscape and precision therapy in prostate cancer: current status and future directions
Naturegeneral

Genomic landscape and precision therapy in prostate cancer: current status and future directions

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fSDU4UTEzZFNKSFlvWmxFbnJOSF9RNHk3SC1vanU5VEZqNGw0eXRCM2JaUElRZ2RFQlVnT05YanAycGZZejNfS3k2MUk0Y3h2bTEtbFlhNHM5RlljYjlV?oc=5" target="_blank">Genomic landscape and precision therapy in prostate cancer: current status and future directions</a>  <font color="#6f6f6f">Nature</font>

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics
Frontiersworld

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNMEVQUEFkVXR6aVpKZ0Eza3ctMWh0NVRONVU2cjNmUHpseHlWVnNZcDBOWEkyQjkwOXhYMFFmZzFnUlA2Y044eHp0MktPeWN1cmNHVmg0cDNDd1ByTXktTnphOHdzVzBIR1RTMzdZS2F4eUt5YVpiZlZBbmh6RHFQOHg4azY1LXZWLVBobXVvajNodw?oc=5" target="_blank">The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics</a>  <font color="#6f6f6f">Frontiers</font>

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
PR Newswireworld

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis

<a href="https://news.google.com/rss/articles/CBMi2gJBVV95cUxPOW9oV0ZWZHo3OG1GVEliTWhvaXJzVGJCN0NMZFNvQWZRT0NraVBiZEhvcWo2dU4xTHpEek9DNkplR05zcEpDaF80MWRkUEd4OTVGMURSUEZjOHNmM0FNUFJobC0xZWxmR29JRzlpOE5rM0dYZE5JcFoyRmwzdW4xTjdrckpqSDZSVklxX2c5QlozbkhQbUZRZFJoRWhtTjUxNUFQQURIZmVmdFJ2aEZmN3IzME5JdWpjUXRKaUpZMDlBQlAzS1dHdHVSdHRidW9FOXR5VFVrX2kwV1lsc1h4eUcyZklFQXpGN183R2t2bndIeER1MWsyVF9BM0E2YjFDU21yc1FhSks2ZDM3N1RwMFd5elJHQUtmZHY4R21VYkFSVTc2X1MxN1hoUVNBWTdLQ01iTHd2QWpHeHJXcXh3dElLWHU0YnJMOGo0a0ViV0xEMnN4eUU1dHJ3?oc=5" target="_blank">EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis</a>  <font color="#6f6f6f">PR Newswire</font>

Graph Therapeutics brings total funding to over $10M to advance precision immunology
Tech.euworld

Graph Therapeutics brings total funding to over $10M to advance precision immunology

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPWmIyaVYxS2VvSGctTzRkODlKblJLZTVNNmJESmJPdkw5QkszOEszYVp0UDNXREZlTGYyVFhtbHo2c1ZxQWZYTENfV2dveFJpVTJsSndwUGR3U0hWeWpfYXg1ZnduVGlobGdocnBqZ0NRYVc1UHBiOF92dDByb0FTYURsMElJR2VidlNqSUZrc1FpRVBwMGtPSFhsQXFCbmVIeGhNLXl5cXlOdHUwNFA2cQ?oc=5" target="_blank">Graph Therapeutics brings total funding to over $10M to advance precision immunology</a>  <font color="#6f6f6f">Tech.eu</font>

A perspective on precision therapeutics in polycystic ovary syndrome: integrating multi-omics, AI-driven stratification, and emerging biologics
Frontierstech

A perspective on precision therapeutics in polycystic ovary syndrome: integrating multi-omics, AI-driven stratification, and emerging biologics

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQUTRNRXVuX0lHaDFacnVGY0ZyTVdtckkwYWZ0YUVWYWpfaWY5amtPUm81TWROWFlJZzdxa0U0SXVBdGRUcnFTVnoxcXhVSHUzNzc5UlgtVDhRNDNPb284c2VqWGZWb0l3ZlFCbDFzZms4VWl2aUtjMXNtMHlBQmdSSGc5aWJiNE1PZkNPeEd2Y1N6V0t2U0E?oc=5" target="_blank">A perspective on precision therapeutics in polycystic ovary syndrome: integrating multi-omics, AI-driven stratification, and emerging biologics</a>  <font color="#6f6f6f">Frontiers</font>

Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction
Naturegeneral

Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9QSXNOOGpQU1ZpdVRrSFdkdVV5REMxUzRJcG5DSHBveUxmY0VSeUU4eUs2NWJZWjZ1N05WSmhQYnFTRElTY3Exb0Zjc0w3TXhyMGFnOUYybktidVFJUTN3?oc=5" target="_blank">Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction</a>  <font color="#6f6f6f">Nature</font>

Kidney-targeted drug delivery: from physiological mechanisms to precision therapeutics
Frontiersgeneral

Kidney-targeted drug delivery: from physiological mechanisms to precision therapeutics

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNR0k4aEE5cUtyLTQwZUZHbGQ3VzFScXBtamJhYTdRY1FxX2FueHR4YXdBd2IxdTJrak1oTzgxRGdlTDYzUGZ0NDk2V1phX2VmNzlnb1NRNkpXM1JQQjlTZElJOW5tWURkLXJGTGtuRGdHYmJjOS1pMzFKVnhXODhySWlYNHVYYUtDLTgtMndkUVk1cDJjZ0w4NWZMeXBzWkltQ3JRV2o4NVljVnc1Si1r?oc=5" target="_blank">Kidney-targeted drug delivery: from physiological mechanisms to precision therapeutics</a>  <font color="#6f6f6f">Frontiers</font>

SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation
Naturegeneral

SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JblZVeWNic3RiRDZHek1Bck9zdDl5a0JoLXd4Nm8zZld4MjRBUnpGVm9QbTRrX0QxbzFkdFZxNTh3eVdXeG1ySnpWaHVMSEJOanpIWC05Z3ROWEVyMmtj?oc=5" target="_blank">SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation</a>  <font color="#6f6f6f">Nature</font>

Nanogenomic synergy in Diabetes care: precision therapeutics for patients with multiple long-term conditions
Frontiersgeneral

Nanogenomic synergy in Diabetes care: precision therapeutics for patients with multiple long-term conditions

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNeV9RTERnOFhwVnY2dVRzUVk2ai1PdGhTRGRkQmQ2blRMYlhPd1VPV1lhUm9xXzh4SmFJb1ZPQ0RXT3FHcDJQS1JHWHBqVVYxb0JleHdyWnFRYkdfUXFuUFQxRDRwelJEaENpR2pxeE5XaTdkMUNCYlVPYmNrMmM3Yy0zd2tNN1g5NEVvMlp2S1dPemNtNEE?oc=5" target="_blank">Nanogenomic synergy in Diabetes care: precision therapeutics for patients with multiple long-term conditions</a>  <font color="#6f6f6f">Frontiers</font>

CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia
Naturegeneral

CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5FUmtyWkFZYV92bk1PckhXQXdoaGhocjF6MzZNTlA3eVluaEJiZGxkRFNzUk96OGpvbV82M3B1NG81TUcyVGZOeDVhcGhHb3JJQm9VTkZ3X1o3cUpweWZB?oc=5" target="_blank">CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia</a>  <font color="#6f6f6f">Nature</font>

Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic
Frontiersworld

Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPSVlza1dqMnhPY0dYUkw5X1BObEFrbURZZVA2VGtWemdOZWp5QTlMU0toc3U2UjBwU3RBc3UzVkxPMGxpcmsyUjllcFlmSGdVajYxUkllb1hvSDNUWHR4ZnRBTGVZWXd6aDM5OEI4RmQtcFF1SFozeFY1d1lVWEc3QS1Jbk5lZUN3Z3E1Wkt6QWdzZw?oc=5" target="_blank">Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic</a>  <font color="#6f6f6f">Frontiers</font>

HRH1-targeting mAb: a precision therapeutic strategy for Glioblastoma - Oncogene
Naturegeneral

HRH1-targeting mAb: a precision therapeutic strategy for Glioblastoma - Oncogene

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9NbGFBU041SWhOMVF1dE02c0VweUpjZVROTzB0MU5Eenl0RUc0NERibTNTNjR5MXVEdF9uZlBGQ1ozSWgxYmcyLTl3cW5pemw5TlJFN0NOYlRaVFd6U3JZ?oc=5" target="_blank">HRH1-targeting mAb: a precision therapeutic strategy for Glioblastoma - Oncogene</a>  <font color="#6f6f6f">Nature</font>

Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy
Frontiersgeneral

Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOaC1BajVjcXd3TE0tNm5sVWJyMnZ0SXhqU1lIYk9BTWNfV3BoS1R4amt3ZmMxek5GMm90dGxIMEJVY0lxY0t1aWJsbDR0bFNBZGdnNGg2cW9rMWRaRzF4M013YjVpcF94ZnEyQklWRndwcUZpV3V6Z0lxN0hJZ0dPdTdCX3JGTUVKLTJuYmNB?oc=5" target="_blank">Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy</a>  <font color="#6f6f6f">Frontiers</font>

Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
Naturegeneral

Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ZY2cyd2NicFdGSDVHUTlsM1d5aENrVlR6OGZCdFR2YVRJMGdNUkw2U3B4QlZDeVFRbHdObzF0YVdpU1hKM1NXNF9rWHRuRTFvVkM0MENCTHhBTkVnQWtB?oc=5" target="_blank">Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer</a>  <font color="#6f6f6f">Nature</font>

Opinion: Tomorrow’s Precision Therapeutics Depend on Precision Diagnostics
BioSpacegeneral

Opinion: Tomorrow’s Precision Therapeutics Depend on Precision Diagnostics

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPajZjZVZyYTl2c24ycGM1eDVrd24zYnNVVTN1QmJuYXExSDFJWEpxZXMzRFhWVEZIbjVubHlzb21oVlZYUko3SHg5NXVMTnNncXVmSDBUbFpKMVltREhaZGNkTVE1M3A3THpLOVYtVF94RXJ1Sktja1dGeFVGWWx0TEQ5U3hPV2FzWVhhbENmbE9UaS02dUdjTXBCNFBXelVZcUZIWG5wWWVWU0lZaUZBazBmM2U?oc=5" target="_blank">Opinion: Tomorrow’s Precision Therapeutics Depend on Precision Diagnostics</a>  <font color="#6f6f6f">BioSpace</font>

Macrophages in osteoporotic fractures: from immunometabolic mechanisms to precision therapeutic approaches
Frontiersworld

Macrophages in osteoporotic fractures: from immunometabolic mechanisms to precision therapeutic approaches

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNQkRIQ2xjUURlYThHd0ZCd2wtSUZQeEQtV3VyTnNBTkg3b2d3TS1pb21YYTBqXzZCR1ZwOVk5MmpVOEoxODJnRTcxVV84b00xRkttbEhFTkdSSG5qQktjUHJHamg3Vjc5V2V1OG9OeTBycU45SFlTMGxJTDNxcXVoYmNYZHBlcnUxUTNMT0xiWmJ2QlAtSGc?oc=5" target="_blank">Macrophages in osteoporotic fractures: from immunometabolic mechanisms to precision therapeutic approaches</a>  <font color="#6f6f6f">Frontiers</font>

Comprehensive multi-omics and machine learning framework for glioma subtyping and precision therapeutics
Naturegeneral

Comprehensive multi-omics and machine learning framework for glioma subtyping and precision therapeutics

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1VcWtVWEk3T1lJZkZKUlJ3NjlXamNjTDRkbkdtdTJEWmJVcGFZdzdiVFVPckxjUzl4ZXN0aFY0WHJnR2p5UU1kS2dpLVI4V2tYOXFOZWgzUS1WRFJxOF9F?oc=5" target="_blank">Comprehensive multi-omics and machine learning framework for glioma subtyping and precision therapeutics</a>  <font color="#6f6f6f">Nature</font>

AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy
Frontierstech

AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPY2N6bWhJVFlKS1pTY1hVVEo0RnJQWS1UZ09YajlvODlHSjg4Ymx0SjZYM0IyZGJidFJybDVobWtYWGxJVFplMnh0anNPMnhObzl5WU9TeFV6dzdCbllXcHhhU0E0aUZjcWluNlhIX1B5TlI4a1lkbG1GV3hWMVpoaTJfRml6MXhFV1dUWEFR?oc=5" target="_blank">AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy</a>  <font color="#6f6f6f">Frontiers</font>

Precision Therapy Could Stop Breast Cancer at the Source
UC San Diego Todaygeneral

Precision Therapy Could Stop Breast Cancer at the Source

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOS29fd1ZFell3NHEzZk1WdEItUnllTkpFTl9wTEF5UkRIUHY5dUFDSkNKMlJpd3ZPd2xLS1gtYTBVdlYwZXlwZ19NekdLcHRtMU9IcXR0dnFUUDJBSG1WT29NX3YzMFM4Q3hiM0hhTmpmVW0wWEcyYTZZa1NrTkFvOU1uajlqNVVvV3dDRmZn?oc=5" target="_blank">Precision Therapy Could Stop Breast Cancer at the Source</a>  <font color="#6f6f6f">UC San Diego Today</font>

Bispecific antibodies: The next wave of precision cancer therapy
Drug Discovery & Developmentgeneral

Bispecific antibodies: The next wave of precision cancer therapy

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPV1NmUUlHcjdHUUktTzUxUUtTclBHRXRsUzRmUnk0UWVoOFdJNWZHOGFsTm15a2J0SEk2dzdGUEN6eldrWlJudWcxM0FSV0szcFRfeDBEZi1kX1BqQ1lQT2ZpOTNUNWx1Uld3allsc1h1LVphbVVQN0VuREkxRDBLb0I2a1lPQzVlcm9RX1ZxamttTW1tVU04ZVJrQ1NOQ0ROdHdSQkV0MA?oc=5" target="_blank">Bispecific antibodies: The next wave of precision cancer therapy</a>  <font color="#6f6f6f">Drug Discovery & Development</font>

Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics
Natureworld

Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBkbXhpa1gzSHZJdXBPOTFoN0pfV2EzRVRWWGNfTHJxMHhnek5leHlXTVl6aU9McEdDRGlPaENsV2dWZlE2MEUtdHlnQm1OVVNhTFU2YUpxVjh5OHRuVk8w?oc=5" target="_blank">Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics</a>  <font color="#6f6f6f">Nature</font>

Epitherapeutics: The Next Frontier in Targeted Precision Therapy
Inside Precision Medicinegeneral

Epitherapeutics: The Next Frontier in Targeted Precision Therapy

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPQVNRXzRBOFZ5MVViTjRPeUhnYnNfLTdrLTFBclBVa2xtUEpfMlBtWTIxd1poNkJZNjR5QUNxN21HdlVQS0FxeUhQdUg5cjhjVm95ZHprc1IwcXVxRXo3MUhnQ3p2QWR3eGpmQU9RaUtaRlFXa0thQWdmYmJVWDMzVUNsODVGM1ZvWmlmYkhhVzBCUFJuM2RxY3NfWExvT3NlUl9Na01NZ0x3djYyTXhUZ0Jmd3RYTFF1MlI2dGRSVXphTHFDclFsRWhn?oc=5" target="_blank">Epitherapeutics: The Next Frontier in Targeted Precision Therapy</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Multifunctional Biomedical Devices with Closed‐Loop Systems for Precision Therapy
Wiley & Sonsworld

Multifunctional Biomedical Devices with Closed‐Loop Systems for Precision Therapy

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1acXlnLTYxWTduTGlYcktSRzFXSXlDckYwWkxId1VUTVAxV0lFOGszSXNwSGcwNlMxdEllVFQtbmNlXzZraHZZZVBxbkVGMl9SWHZSV3hVQ05EeWNxWWY0UjY4NFJMVkFDRzN5VnRiZGdRZzFldVE?oc=5" target="_blank">Multifunctional Biomedical Devices with Closed‐Loop Systems for Precision Therapy</a>  <font color="#6f6f6f">Wiley & Sons</font>

"Precision therapeutics an" — Live Google News Trends & Headlines